Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Runx1 helps control the KAP5 gene in human hair follicles.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Copper treatments increase copper in all tissues, but brindled female mice accumulate much more copper in their kidneys without clinical effects, unlike brindled male mice where brain copper deficiency is clinically significant.

Certain SPINK5 gene mutations are common in Israeli families with Comèl-Netherton syndrome.

Fernblock® helps protect skin cells from pollution and stress, reducing inflammation and damage.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

Finasteride, a medication, is being re-evaluated for its effects and uses.

The KRTAP36-2 gene in sheep affects wool yield.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

The bio-based complex effectively repairs and protects chemically damaged hair.

A specific mutation in the TRPV3 gene causes hair follicle cells to develop improperly, leading to hair loss.

Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Twist1 is crucial for UVB-induced skin cancer development.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

QLT0267 stops hair follicle cell growth and movement.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Basonuclin 1 (BNC1) helps skin cells multiply and move, which is crucial for wound healing.

The NF-κB effector p65/RelA activates hair keratin genes, aiding hair formation.